Atai Beckley N.V.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Atai Beckley N.V.
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.
/ 
Frequently asked questions
To buy Atai Beckley N.V. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Atai Beckley N.V. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Atai Beckley N.V. is ATAI:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Atai Beckley N.V. has its primary listing on NASDAQ. You can trade Atai Beckley N.V. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Atai Beckley N.V. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Atai Beckley N.V. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Atai Beckley N.V..